Pharma News - Chemdiv

Wistar scientists move HIV vaccine research forward by developing an immunogen that produces tier-2 antibodies—the kind that matter for combatting HIV

The vaccine delivery system uses DNA to encode genetic instruction in vivo, producing a more efficacious immune response.

Covid medications help big pharma groups beat expectations

Covid was the common currency as three top pharma groups reported results.

Bayer will discontinue phase II development candidate eliapixant

Review of development program led to reassessment of benefit-risk ratio in all four potential indications for the investigational P2X3 receptor antagonist.

Eli Lilly Delays Application for Experimental Alzheimer’s Drug

Eli Lilly said it will hold off on seeking accelerated approval of its investigational Alzheimer’s drug, donanemab, until later this year, rather than completing filing during the first quarter a...

Navitor Pharmaceuticals Announces Janssen Has Acquired Anakuria Therapeutics, Inc.

Today, privately held Navitor Pharmaceuticals, LLC, announced that Janssen Pharmaceuticals, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson has acquired Anakuria Therapeu...

GSK to get $1.25 bln to settle HIV drug patent row with Gilead

Britain's GlaxoSmithKline will receive $1.25 billion from Gilead Sciences as part of a settlement between its HIV medicines unit and the U.S.-based drugmaker, ending a long-drawn patent d...

FDA places partial clinical hold on umbralisib and ublituximab trials in CLL and NHL

The U.S. Food and Drug Administration (FDA) has placed a partial clinical hold on a series of trials investigating the use using umbralisib in combination with ublituximab (U2) as a treatment for c...

Timber Pharmaceuticals Announces Successful End-of-Phase 2 Meeting with FDA for TMB-001 in Moderate to Severe Congenital Ichthyosis

Timber Pharmaceuticals announced the successful completion of an End-of-Phase 2 meeting with the U.S. FDA resulting in a clear path towards a pivotal Phase 3 study for its lead asset, TMB-001, a to...

Researchers develop new approach to discover pervasive ‘forever’ chemicals known as PFAS

PFAS, a family of thousands of human-made chemicals, are everywhere, and some of them are known to be harmful for our bodies and the environment.

FDA Approves First Generic of Restasis for Dry Eye

The FDA approved the first generic of cyclosporine ophthalmic emulsion (Restasis) for dry eye, a condition that affects millions of Americans each year.

A pill that releases RNA in the stomach could offer a new way to administer vaccines

Like most vaccines, RNA vaccines have to be injected, which can be an obstacle for people who fear needles.

FDA Approves Glenmark Pharmaceuticals’ Generic Metronidazole Gel

Glenmark Pharmaceuticals USA has received FDA’s approval for its generic version of MetroGel-Vaginal Gel (metronidazole) 0.75 percent made by Bausch Health.

Pharma News, 2022